Citron Research says Valeant Pharma (VRX) has better chance than HLF of 'going to $0'
Citron Research says Valeant Pharma (NYSE: VRX) has better chance than HLF of 'going to $0'. Citron said it will have more details on Monday. Calls company 'dirtier' than anyone has reported.
$VRX has a better chance of going to 0 than $HLF EVER will. Citron to update full story on Monday. Dirtier than anyone has reported!!
— Citron Research (@CitronResearch) October 30, 2015
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PowerSchool Holdings, Inc. (PWSC) Mentioned Cautiously at Spruce Point
- Globe Life (GL) erasing some of earlier gains, slips under $54
- Stocks have priced in much of the 2024 optimism - Wells Fargo
Create E-mail Alert Related Categories
Short Sales, Trader TalkRelated Entities
Citron ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!